Tag Archives: EMEA

Discussing Baxter’s Convenient Patent of Celvapan, Along With Their ‘Accidental’ Adulteration of ‘Vaccine’ With Avian Flu

By | |
Leave a comment

The following correspondence originally took place on my Facebook wall, upon my post, “Baxter’s H5N1 Avian Flu Virus Vaccine Conveniently Approved Just Months Before Company “Accidentally” Released “Vaccines” Contaminated with Exact Same Virus to 18 Countries“…

Celvapan

Celvapan

Rayn: Baxter’s Cell Culture-Based Pandemic Flu Vaccine Receives EMEA Positive Opinion:
http://biopharminternational.findpharma.com/biopharm/Baxters-Cell-Culture-Based-Pandemic-Flu-Vaccine-Re/ArticleStandard/Article/detail/575432?ref=25

Due to the fact that the world narrowly averted a global avian flu pandemic this month due to the diligence of the good individuals at the National Microbiology Laboratory in Canada, I decided to further research the topic today, and came upon this article, dated January 19, 2009. As it turns out, the company responsible for almost causing the above-mentioned bio-disaster, Baxter International Inc., just so happens to own the rights to “Celvapan,” the world’s first cell-culture based H5N1 (avian flu) pandemic vaccine! Apparently, though it’s still in trial stages, it is very close to receiving full market authorization from the European Union. In other words, if a global avian flu pandemic ever did take place, Baxter International would be in a position to make a great deal of money!!!

Rebekah P.: A sickening snake eating its own tail!!!

Rayn: Well, since Baxter made no real effort to cover their tracks, and destroyed no evidence, as I found this article online relatively easily (they could have had it removed), I’d say they more resemble a diseased parasite – feeding on its host until its host dies, even at the risk of dying itself!

Baxter’s H5N1 Avian Flu Virus Vaccine Conveniently Approved Just Months Before Company “Accidentally” Released “Vaccines” Contaminated with Exact Same Virus to 18 Countries

By | |
1 Comment

I originally posted the following news commentary onto my Facebook wall…

Celvapan

Celvapan

Baxter’s Cell Culture-Based Pandemic Flu Vaccine Receives EMEA Positive Opinion:
http://biopharminternational.findpharma.com/biopharm/Baxters-Cell-Culture-Based-Pandemic-Flu-Vaccine-Re/ArticleStandard/Article/detail/575432?ref=25

(BioPharm Bulletin) – Celvapan, the first cell culture-based H5N1 (avian flu) pandemic vaccine, has moved closer to approval in the European Union. On December 18, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA), issued a positive opinion, recommending market authorization for the vaccine, made by Baxter International, Inc. (Deerfield, IL).

The positive opinion precedes the licensure of the “mock-up” vaccine, which allows Celvapan to be used if the World Health Organization (WHO) officially declares a pandemic. The positive opinion was based on results from a comprehensive clinical development program, including a Phase 3 clinical trial that demonstrated vaccines for two different H5N1 virus strains were well tolerated and generated a functional immune response.

(Read entire article here…)

My Commentary: Due to the fact that the world narrowly averted a global avian flu pandemic this month due to the diligence of the good individuals at the National Microbiology Laboratory in Canada, I decided to further research the topic today, and came upon this article, dated January 19, 2009. As it turns out, the company responsible for almost causing the above-mentioned bio-disaster, Baxter International Inc., just so happens to own the rights to “Celvapan,” the world’s first cell-culture based H5N1 (avian flu) pandemic vaccine! Apparently, though it’s still in trial stages, it is very close to receiving full market authorization from the European Union. In other words, if a global avian flu pandemic ever did take place, Baxter International would be in a position to make a great deal of money!!!